2m 2m 2m 2m 2m 2m 2m
Pulse Bioscience (PLSE)
NASDAQ
$24.99+$0.70 (+2.90%)
Price as of Jun 03, 2026 6:04 PM EDT- $1.7BMarket Cap
- 37.72%1-Year Change
- Medical Instruments & SuppliesIndustry
Pulse Bioscience (PLSE)
$24.99+$0.70 (+2.90%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 350,000 N/A | 0 N/A | 0 -100.00% | 700,000 -50.63% | |
Cost of Revenue | 539,000 N/A | N/A N/A | 0 -100.00% | 11.9M +506.91% | |
Gross Profit | -189,000 N/A | 0 N/A | 0 +100.00% | -11.2M +1,944.36% | |
Sales and Marketing Expense | 32.0M +931.20% | 3.1M N/A | 0 -100.00% | 12.0M -18.52% | |
Research and Development Expense | -44.7M +38.30% | -32.3M +16.33% | -27.8M +33.39% | -20.8M -27.24% | |
Depreciation and Amortization Expense | 665,000 -0.15% | 666,000 +0.15% | 665,000 0.00% | 665,000 -0.15% | |
Total Operating Expenses | 77.3M +37.39% | 56.3M +29.11% | 43.6M -25.84% | 58.8M -8.81% | |
Operating Profit | -76.9M +36.76% | -56.3M +29.11% | -43.6M -24.95% | -58.1M -7.87% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -1.1M 0.00% | -1.1M +145.54% | -448,000 -30.65% | |
Interest Income and Expense and Net | 0 +100.00% | -1.1M 0.00% | -1.1M +145.54% | -448,000 -30.65% | |
Total Nonoperating Income and Expense | 4.2M +55.61% | 2.7M +95.89% | 1.4M +404.46% | -448,000 -30.65% | |
Income before Taxes | -76.9M +43.58% | -53.6M +26.95% | -42.2M -27.85% | -58.5M -8.10% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -72.8M +35.82% | -53.6M +26.95% | -42.2M -27.85% | -58.5M -8.10% | |
Net Income from Continuing Operations Applicable to Common | -72.8M +35.82% | -53.6M +26.95% | -42.2M -27.85% | -58.5M -8.10% | |
Basic EPS and Net Income | -1.08 +17.39% | -0.92 +4.55% | -0.88 -48.84% | -1.72 -24.56% | |
Diluted EPS and Net Income | -1.08 +17.39% | -0.92 +4.55% | -0.88 -48.84% | -1.72 -24.56% | |
Basic Weighted Average Shares | 67.4M +15.41% | 58.4M +21.57% | 48.0M +41.56% | 33.9M +21.35% | |
Diluted Weighted Average Shares | 67.4M +15.41% | 58.4M +21.57% | 48.0M +41.56% | 33.9M +21.35% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 80.7M -31.60% | 118.0M +166.06% | 44.4M -27.44% | 61.1M +113.67% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 80.7M -31.60% | 118.0M +166.06% | 44.4M -27.44% | 61.1M +66.93% | |
Total Current Assets | 83.4M -30.16% | 119.4M +163.52% | 45.3M -27.06% | 62.1M +69.66% | |
Accumulated Depreciation | 4.4M +10.23% | 4.0M +14.15% | 3.5M +17.71% | 3.0M +23.25% | |
Property and Plant and Equipment and Net | 1.1M -9.40% | 1.2M -24.08% | 1.5M -22.08% | 2.0M -20.35% | |
Total Long-Term Assets | 691,000 +2.07% | 677,000 +85.48% | 365,000 0.00% | 365,000 0.00% | |
Total Assets | 94.5M -28.63% | 132.5M +123.92% | 59.2M -24.04% | 77.9M +43.55% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 917,000 +110.32% | |
Total Current Liabilities | 7.9M -21.20% | 10.1M +49.90% | 6.7M +12.16% | 6.0M -29.79% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 N/A | 0 N/A | |
Total Long-Term Liabilities | 6.0M -20.99% | 7.5M -6.72% | 8.1M -11.57% | 9.1M -8.92% | |
Total Liabilities | 13.9M -21.11% | 17.6M +18.95% | 14.8M -81.54% | 80.1M +331.73% | |
Retained Earnings | -463.3M +18.64% | -390.5M +15.90% | -336.9M +14.32% | -294.7M +24.77% | |
Total Stockholders Equity | 80.7M -29.78% | 114.9M +158.93% | 44.4M +2,073.31% | -2.2M -106.30% | |
Total Shares Outstanding | 67.8M +2.90% | 65.9M +19.55% | 55.1M +48.10% | 37.2M +25.30% | |
Cash Flow | |||||
Cash from Operating Activities | -54.1M +48.92% | -36.3M +9.99% | -33.0M -29.72% | -47.0M -13.09% | |
Capital Expenditures | 315,000 +152.00% | 125,000 +3.31% | 121,000 -69.83% | 401,000 -8.24% | |
Cash from Investing Activities | -335,000 +168.00% | -125,000 +3.31% | -121,000 -69.83% | -401,000 -105.30% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.2M -84.43% | 110.1M +572.08% | 16.4M -79.50% | 79.9M +27.52% | |
Financials Ratio | |||||
Gross Margin | -54.00% N/A | N/A N/A | N/A N/A | -1,606.29% +4,041.30% | |
Operating Margin | -21,982.57% N/A | N/A N/A | N/A N/A | -8,293.86% +86.64% | |
Return on Assets | -64.12% +14.65% | -55.93% -9.21% | -61.61% -30.43% | -88.56% -33.54% | |
Return on Equity | -74.45% +10.61% | -67.31% -66.42% | -200.47% -42.71% | -349.89% +61.00% | |
Revenue Growth | N/A N/A | N/A N/A | -100.00% +97.49% | -50.63% -104.43% | |
Current Ratio | 10.53 -11.37% | 11.88 +75.80% | 6.76 -34.97% | 10.39 +141.66% | |
Cash Ratio | 10.19 -13.20% | 11.74 +77.50% | 6.61 -35.30% | 10.22 +204.34% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.00 +100.00% | -0.41 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.00 -100.00% | 0.01 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow